Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV6209 (Ozalin) for premedication in paediatric anaesthesia
2019-001853-25Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of midazolam in preoperative anxiety (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Sedation score after premedication. Started May 2019; status: completed.
02
Drugs
midazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on 2019-001853-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001853-25.